As of 2025-07-10, the Relative Valuation of Werewolf Therapeutics Inc (HOWL) is (21.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.06 USD, the upside of Werewolf Therapeutics Inc based on Relative Valuation is -2155.3%.
The range of the Relative Valuation is (21.33) - (30.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 18.7x | 13.3x |
| Forward P/E multiples | 12.8x - 21.3x | 13.7x |
| Fair Price | (21.33) - (30.24) | (21.79) |
| Upside | -2112.7% - -2953.1% | -2155.3% |
| Date | P/E |
| 2025-07-09 | -0.67 |
| 2025-07-08 | -0.66 |
| 2025-07-07 | -0.65 |
| 2025-07-03 | -0.66 |
| 2025-07-02 | -0.66 |
| 2025-07-01 | -0.65 |
| 2025-06-30 | -0.68 |
| 2025-06-27 | -0.63 |
| 2025-06-26 | -0.71 |
| 2025-06-25 | -0.74 |
| 2025-06-24 | -0.77 |
| 2025-06-23 | -0.77 |
| 2025-06-20 | -0.74 |
| 2025-06-18 | -0.77 |
| 2025-06-17 | -0.75 |
| 2025-06-16 | -0.81 |
| 2025-06-13 | -0.76 |
| 2025-06-12 | -0.80 |
| 2025-06-11 | -0.76 |
| 2025-06-10 | -0.82 |
| 2025-06-09 | -0.87 |
| 2025-06-06 | -0.88 |
| 2025-06-05 | -0.76 |
| 2025-06-04 | -0.81 |
| 2025-06-03 | -0.84 |
| 2025-06-02 | -0.74 |
| 2025-05-30 | -0.75 |
| 2025-05-29 | -0.79 |
| 2025-05-28 | -0.76 |
| 2025-05-27 | -0.74 |
| 2025-05-23 | -0.71 |
| 2025-05-22 | -0.69 |
| 2025-05-21 | -0.67 |
| 2025-05-20 | -0.71 |
| 2025-05-19 | -0.69 |
| 2025-05-16 | -0.69 |
| 2025-05-15 | -0.69 |
| 2025-05-14 | -0.61 |
| 2025-05-13 | -0.63 |
| 2025-05-12 | -0.62 |
| 2025-05-09 | -0.50 |
| 2025-05-08 | -0.54 |
| 2025-05-07 | -0.57 |
| 2025-05-06 | -0.58 |
| 2025-05-05 | -0.59 |
| 2025-05-02 | -0.56 |
| 2025-05-01 | -0.54 |
| 2025-04-30 | -0.56 |
| 2025-04-29 | -0.52 |
| 2025-04-28 | -0.52 |